ÂÜÀòÂÒÂ×

Yangzhong Tang is the Director of Discovery Biology at Eikon Therapeutics since March 2020. Prior to that, Yangzhong has held various positions in companies such as FibroGen, Inc., Cleave Biosciences, Inc., and Sanofi, focusing on cancer target discovery, functional genomics, and oncology research. Yangzhong has a Ph.D. in Chemical and Biomolecular Engineering from The Ohio State University and a BS in Control Science and Engineering from Zhejiang University.